$SEM
SELECT MEDICAL HOLDINGS CORP

2023 Q2 Form 10-Q Financial Statement

#000162828023015781 Filed on May 04, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1
Revenue $1.675B $1.665B
YoY Change 5.67% 4.09%
Cost Of Revenue $1.424B $1.419B
YoY Change 2.38% 0.84%
Gross Profit $250.9M $246.2M
YoY Change 29.22% 27.85%
Gross Profit Margin 14.98% 14.78%
Selling, General & Admin $42.51M $42.28M
YoY Change 14.06% 12.7%
% of Gross Profit 16.94% 17.18%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $49.94M $52.43M
YoY Change -2.24% 2.72%
% of Gross Profit 19.9% 21.3%
Operating Expenses $91.72M $94.70M
YoY Change 25.26% 6.95%
Operating Profit $159.2M $151.5M
YoY Change 31.61% 45.65%
Interest Expense $49.00M $48.57M
YoY Change 19.35% 36.77%
% of Operating Profit 30.78% 32.07%
Other Income/Expense, Net
YoY Change
Pretax Income $120.7M $111.4M
YoY Change 40.22% 50.87%
Income Tax $28.85M $26.19M
% Of Pretax Income 23.9% 23.5%
Net Earnings $78.24M $70.81M
YoY Change 41.72% 44.16%
Net Earnings / Revenue 4.67% 4.25%
Basic Earnings Per Share $0.61 $0.56
Diluted Earnings Per Share $0.61 $0.56
COMMON SHARES
Basic Shares Outstanding 127.1M shares 127.2M shares
Diluted Shares Outstanding 122.6M shares 122.6M shares

Balance Sheet

Concept 2023 Q2 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $101.2M $83.70M
YoY Change 6.86% -36.05%
Cash & Equivalents $101.2M $83.70M
Short-Term Investments
Other Short-Term Assets $138.2M $143.7M
YoY Change -14.76% 4.33%
Inventory
Prepaid Expenses
Receivables $964.7M $997.3M
Other Receivables $0.00 $0.00
Total Short-Term Assets $1.304B $1.314B
YoY Change 6.83% 5.03%
LONG-TERM ASSETS
Property, Plant & Equipment $1.004B $987.3M
YoY Change 5.09% 3.61%
Goodwill $3.486B $3.485B
YoY Change 0.28% 0.55%
Intangibles $346.7M $346.6M
YoY Change -5.32% -6.03%
Long-Term Investments
YoY Change
Other Assets $358.9M $354.0M
YoY Change -9.3% -10.42%
Total Long-Term Assets $6.397B $6.386B
YoY Change 1.05% 1.61%
TOTAL ASSETS
Total Short-Term Assets $1.304B $1.314B
Total Long-Term Assets $6.397B $6.386B
Total Assets $7.702B $7.700B
YoY Change 1.99% 2.17%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $186.8M $174.1M
YoY Change -19.3% -26.89%
Accrued Expenses $904.5M $852.9M
YoY Change -1.27% -1.69%
Deferred Revenue
YoY Change
Short-Term Debt $31.49M $31.24M
YoY Change 0.63% -10.1%
Long-Term Debt Due $57.21M $113.9M
YoY Change 29.98% 364.63%
Total Short-Term Liabilities $1.188B $1.186B
YoY Change -4.31% -0.29%
LONG-TERM LIABILITIES
Long-Term Debt $3.695B $3.767B
YoY Change -0.76% 0.76%
Other Long-Term Liabilities $105.1M $106.7M
YoY Change -2.43% 1.48%
Total Long-Term Liabilities $105.1M $106.7M
YoY Change -2.43% 1.48%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.188B $1.186B
Total Long-Term Liabilities $105.1M $106.7M
Total Liabilities $6.166B $6.247B
YoY Change -0.64% 1.95%
SHAREHOLDERS EQUITY
Retained Earnings $696.9M $635.5M
YoY Change 23.23% 6.61%
Common Stock $474.1M $462.3M
YoY Change 7.28% -5.64%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.246B $1.170B
YoY Change
Total Liabilities & Shareholders Equity $7.702B $7.700B
YoY Change 1.99% 2.17%

Cashflow Statement

Concept 2023 Q2 2023 Q1
OPERATING ACTIVITIES
Net Income $78.24M $70.81M
YoY Change 41.72% 44.16%
Depreciation, Depletion And Amortization $49.94M $52.43M
YoY Change -2.24% 2.72%
Cash From Operating Activities $234.8M $51.44M
YoY Change 36.79% 711.74%
INVESTING ACTIVITIES
Capital Expenditures $59.51M $58.89M
YoY Change -228.45% -225.7%
Acquisitions $397.0K
YoY Change -92.34%
Other Investing Activities -$7.299M -$10.18M
YoY Change -41.28% 19.93%
Cash From Investing Activities -$66.81M -$69.06M
YoY Change 13.7% 24.82%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -150.6M $3.419M
YoY Change 0.96% -96.76%
NET CHANGE
Cash From Operating Activities 234.8M $51.44M
Cash From Investing Activities -66.81M -$69.06M
Cash From Financing Activities -150.6M $3.419M
Net Change In Cash 17.46M -$14.20M
YoY Change -148.23% -125.11%
FREE CASH FLOW
Cash From Operating Activities $234.8M $51.44M
Capital Expenditures $59.51M $58.89M
Free Cash Flow $175.3M -$7.445M
YoY Change -19.58% -114.0%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001320414
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
001-34465
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
SELECT MEDICAL HOLDINGS CORP
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-1764048
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
4714 Gettysburg Road
CY2023Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
P.O. Box 2034
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Mechanicsburg
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
PA
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
17055
CY2023Q1 dei City Area Code
CityAreaCode
717
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
972-1100
CY2023Q1 dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
CY2023Q1 dei Trading Symbol
TradingSymbol
SEM
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
127126909 shares
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
97906000 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
83703000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
941312000 usd
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
997274000 usd
CY2022Q4 us-gaap Prepaid Taxes
PrepaidTaxes
31868000 usd
CY2023Q1 us-gaap Prepaid Taxes
PrepaidTaxes
16893000 usd
CY2022Q4 us-gaap Derivative Assets Current
DerivativeAssetsCurrent
74857000 usd
CY2023Q1 us-gaap Derivative Assets Current
DerivativeAssetsCurrent
72127000 usd
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
125370000 usd
CY2023Q1 us-gaap Other Assets Current
OtherAssetsCurrent
143736000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
1271313000 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
1313733000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1169740000 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1186534000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1001440000 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
987283000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
3484200000 usd
CY2023Q1 us-gaap Goodwill
Goodwill
3484594000 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
351662000 usd
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
346606000 usd
CY2022Q4 us-gaap Derivative Assets Noncurrent
DerivativeAssetsNoncurrent
45200000 usd
CY2023Q1 us-gaap Derivative Assets Noncurrent
DerivativeAssetsNoncurrent
26994000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
341738000 usd
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
353992000 usd
CY2022Q4 us-gaap Assets
Assets
7665293000 usd
CY2023Q1 us-gaap Assets
Assets
7699736000 usd
CY2022Q4 sem Book Overdrafts
BookOverdrafts
31961000 usd
CY2023Q1 sem Book Overdrafts
BookOverdrafts
31237000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
236784000 usd
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
239713000 usd
CY2022Q4 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
44351000 usd
CY2023Q1 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
113894000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
186729000 usd
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
174101000 usd
CY2022Q4 sem Accrued Salaries Accrued Bonuses And Accrued Payroll Taxes Current
AccruedSalariesAccruedBonusesAndAccruedPayrollTaxesCurrent
209789000 usd
CY2023Q1 sem Accrued Salaries Accrued Bonuses And Accrued Payroll Taxes Current
AccruedSalariesAccruedBonusesAndAccruedPayrollTaxesCurrent
171815000 usd
CY2022Q4 us-gaap Accrued Vacation Current
AccruedVacationCurrent
150695000 usd
CY2023Q1 us-gaap Accrued Vacation Current
AccruedVacationCurrent
156433000 usd
CY2022Q4 us-gaap Interest Payable Current
InterestPayableCurrent
29837000 usd
CY2023Q1 us-gaap Interest Payable Current
InterestPayableCurrent
10241000 usd
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
264525000 usd
CY2023Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
274654000 usd
CY2022Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
480000 usd
CY2023Q1 us-gaap Taxes Payable Current
TaxesPayableCurrent
13618000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1155151000 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
1185706000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1008394000 usd
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1024676000 usd
CY2022Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
3835211000 usd
CY2023Q1 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
3766838000 usd
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
169793000 usd
CY2023Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
163024000 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
106137000 usd
CY2023Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
106652000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
6274686000 usd
CY2023Q1 us-gaap Liabilities
Liabilities
6246896000 usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
34043000 usd
CY2023Q1 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
34399000 usd
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
700000000 shares
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
700000000 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
127173871 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
127173871 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
127176279 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
127176279 shares
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
127000 usd
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
127000 usd
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
452183000 usd
CY2023Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
462185000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
581010000 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
635483000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
88602000 usd
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
72654000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1121922000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
1170449000 usd
CY2022Q4 us-gaap Minority Interest
MinorityInterest
234642000 usd
CY2023Q1 us-gaap Minority Interest
MinorityInterest
247992000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1356564000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1418441000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7665293000 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7699736000 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1599547000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1664980000 usd
CY2022Q1 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
1407010000 usd
CY2023Q1 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
1418819000 usd
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
37513000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
42279000 usd
CY2022Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
51039000 usd
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
52425000 usd
CY2022Q1 us-gaap Costs And Expenses
CostsAndExpenses
1495562000 usd
CY2023Q1 us-gaap Costs And Expenses
CostsAndExpenses
1513523000 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
103985000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
151457000 usd
CY2022Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
5397000 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
8556000 usd
CY2022Q1 us-gaap Interest Expense
InterestExpense
35514000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
48571000 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
73868000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
111442000 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
17942000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
26185000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
55926000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
85257000 usd
CY2022Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
6809000 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
14452000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
49117000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
70805000 usd
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.37
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.37
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.56
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.56
CY2022Q1 us-gaap Profit Loss
ProfitLoss
55926000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
85257000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
39814000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
-2696000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
-39000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
13252000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
13284000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
-5175000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
39853000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-15948000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
95779000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
69309000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
6809000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
14452000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
88970000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
54857000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1356564000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
70805000 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossAttributableToNonredeemableNoncontrollingInterest
-12811000 usd
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.125
CY2023Q1 us-gaap Dividends Common Stock
DividendsCommonStock
15897000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
0 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
10003000 usd
CY2023Q1 us-gaap Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
2731000 usd
CY2023Q1 us-gaap Noncontrolling Interest Increase From Business Combination
NoncontrollingInterestIncreaseFromBusinessCombination
3877000 usd
CY2023Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
6069000 usd
CY2023Q1 us-gaap Minority Interest Change In Redemption Value
MinorityInterestChangeInRedemptionValue
-436000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-15948000 usd
CY2023Q1 us-gaap Stockholders Equity Other
StockholdersEquityOther
0 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1418441000 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1325902000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
49117000 usd
CY2022Q1 us-gaap Net Income Loss Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossAttributableToNonredeemableNoncontrollingInterest
-4891000 usd
CY2022Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.125
CY2022Q1 us-gaap Dividends Common Stock
DividendsCommonStock
16691000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
0 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
8288000 usd
CY2022Q1 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
51676000 usd
CY2022Q1 us-gaap Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
5229000 usd
CY2022Q1 us-gaap Noncontrolling Interest Increase From Business Combination
NoncontrollingInterestIncreaseFromBusinessCombination
12463000 usd
CY2022Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
9097000 usd
CY2022Q1 us-gaap Minority Interest Change In Redemption Value
MinorityInterestChangeInRedemptionValue
-1381000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
39853000 usd
CY2022Q1 us-gaap Stockholders Equity Other
StockholdersEquityOther
2000 usd
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1366896000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
55926000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
85257000 usd
CY2022Q1 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
7486000 usd
CY2023Q1 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
2566000 usd
CY2022Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
51039000 usd
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
52425000 usd
CY2022Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
94000 usd
CY2023Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
429000 usd
CY2022Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
5397000 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
8556000 usd
CY2022Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
23000 usd
CY2023Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
7000 usd
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
8823000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
10181000 usd
CY2022Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
558000 usd
CY2023Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
565000 usd
CY2022Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
420000 usd
CY2023Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-2601000 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
52225000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
55397000 usd
CY2022Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
1819000 usd
CY2023Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
11742000 usd
CY2022Q1 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-2686000 usd
CY2023Q1 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-3659000 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
16074000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-4564000 usd
CY2022Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-14377000 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-20775000 usd
CY2022Q1 sem Increase Decrease In Government Advances Cares Act
IncreaseDecreaseInGovernmentAdvancesCARESAct
-62928000 usd
CY2023Q1 sem Increase Decrease In Government Advances Cares Act
IncreaseDecreaseInGovernmentAdvancesCARESAct
0 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
6337000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
51440000 usd
CY2022Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
5186000 usd
CY2023Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
397000 usd
CY2022Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
46845000 usd
CY2023Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
58885000 usd
CY2022Q1 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
3337000 usd
CY2023Q1 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
9800000 usd
CY2022Q1 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
37000 usd
CY2023Q1 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
20000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-55331000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-69062000 usd
CY2022Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
280000000 usd
CY2023Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
225000000 usd
CY2022Q1 us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
100000000 usd
CY2023Q1 us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
210000000 usd
CY2022Q1 us-gaap Proceeds From Other Debt
ProceedsFromOtherDebt
15794000 usd
CY2023Q1 us-gaap Proceeds From Other Debt
ProceedsFromOtherDebt
21448000 usd
CY2022Q1 us-gaap Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
9188000 usd
CY2023Q1 us-gaap Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
11170000 usd
CY2022Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
16691000 usd
CY2023Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
15897000 usd
CY2022Q1 us-gaap Payments For Repurchase Of Equity
PaymentsForRepurchaseOfEquity
51676000 usd
CY2023Q1 us-gaap Payments For Repurchase Of Equity
PaymentsForRepurchaseOfEquity
0 usd
CY2022Q1 us-gaap Increase Decrease In Book Overdrafts
IncreaseDecreaseInBookOverdrafts
-7608000 usd
CY2023Q1 us-gaap Increase Decrease In Book Overdrafts
IncreaseDecreaseInBookOverdrafts
-724000 usd
CY2022Q1 us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
5229000 usd
CY2023Q1 us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
2731000 usd
CY2022Q1 us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
10295000 usd
CY2023Q1 us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
7969000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
105565000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3419000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
56571000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-14203000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
74310000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
97906000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
130881000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
83703000 usd
CY2023Q1 us-gaap Derivative Cash Received On Hedge
DerivativeCashReceivedOnHedge
17828000 usd
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
53517000 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
84531000 usd
CY2022Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
923000 usd
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
336000 usd
CY2023Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, and expenses. Actual results could differ from those estimates.</span></div>
CY2022Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
34043000 usd
CY2022Q1 us-gaap Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
1918000 usd
CY2023Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
Credit Risk ConcentrationsFinancial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash balances and accounts receivable. The Company’s excess cash is held with large financial institutions. The Company grants unsecured credit to its patients, most of whom reside in the service area of the Company’s facilities and are insured under third-party payor agreements.Because of the diversity in the Company’s non-governmental third-party payor base, as well as their geographic dispersion, accounts receivable due from the Medicare program represent the Company’s only significant concentration of credit risk.
CY2021Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
39033000 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
1641000 usd
CY2022Q1 sem Noncontrolling Interest Distributionsto Redeemable Noncontrolling Interests
NoncontrollingInterestDistributionstoRedeemableNoncontrollingInterests
1198000 usd
CY2023Q1 sem Noncontrolling Interest Distributionsto Redeemable Noncontrolling Interests
NoncontrollingInterestDistributionstoRedeemableNoncontrollingInterests
1900000 usd
CY2022Q1 us-gaap Minority Interest Change In Redemption Value
MinorityInterestChangeInRedemptionValue
-1381000 usd
CY2023Q1 us-gaap Minority Interest Change In Redemption Value
MinorityInterestChangeInRedemptionValue
-436000 usd
CY2022Q1 us-gaap Temporary Equity Other Changes
TemporaryEquityOtherChanges
536000 usd
CY2023Q1 us-gaap Temporary Equity Other Changes
TemporaryEquityOtherChanges
179000 usd
CY2022Q1 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
41670000 usd
CY2023Q1 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
34399000 usd
CY2022Q1 sem Operating Lease Cost Unrelated Parties
OperatingLeaseCostUnrelatedParties
73962000 usd
CY2022Q1 sem Operating Lease Cost Related Parties
OperatingLeaseCostRelatedParties
1809000 usd
CY2022Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
75771000 usd
CY2023Q1 sem Operating Lease Cost Unrelated Parties
OperatingLeaseCostUnrelatedParties
76632000 usd
CY2023Q1 sem Operating Lease Cost Related Parties
OperatingLeaseCostRelatedParties
1834000 usd
CY2023Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
78466000 usd
CY2022Q1 sem Finance Lease Right Of Use Asset Amortization Unrelated Parties
FinanceLeaseRightOfUseAssetAmortizationUnrelatedParties
347000 usd
CY2022Q1 sem Finance Lease Right Of Use Asset Amortization Related Parties
FinanceLeaseRightOfUseAssetAmortizationRelatedParties
0 usd
CY2022Q1 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
347000 usd
CY2023Q1 sem Finance Lease Right Of Use Asset Amortization Unrelated Parties
FinanceLeaseRightOfUseAssetAmortizationUnrelatedParties
394000 usd
CY2023Q1 sem Finance Lease Right Of Use Asset Amortization Related Parties
FinanceLeaseRightOfUseAssetAmortizationRelatedParties
0 usd
CY2023Q1 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
394000 usd
CY2022Q1 sem Finance Lease Interest Expense Unrelated Parties
FinanceLeaseInterestExpenseUnrelatedParties
340000 usd
CY2022Q1 sem Finance Lease Interest Expense Related Parties
FinanceLeaseInterestExpenseRelatedParties
0 usd
CY2022Q1 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
340000 usd
CY2023Q1 sem Finance Lease Interest Expense Unrelated Parties
FinanceLeaseInterestExpenseUnrelatedParties
320000 usd
CY2023Q1 sem Finance Lease Interest Expense Related Parties
FinanceLeaseInterestExpenseRelatedParties
0 usd
CY2023Q1 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
320000 usd
CY2022Q1 sem Short Term Lease Cost Unrelated Parties
ShortTermLeaseCostUnrelatedParties
35000 usd
CY2022Q1 sem Short Term Lease Cost Related Parties
ShortTermLeaseCostRelatedParties
0 usd
CY2022Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
35000 usd
CY2023Q1 sem Short Term Lease Cost Unrelated Parties
ShortTermLeaseCostUnrelatedParties
0 usd
CY2023Q1 sem Short Term Lease Cost Related Parties
ShortTermLeaseCostRelatedParties
0 usd
CY2023Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
0 usd
CY2022Q1 sem Variable Lease Cost Unrelated Parties
VariableLeaseCostUnrelatedParties
13655000 usd
CY2022Q1 sem Variable Lease Cost Related Parties
VariableLeaseCostRelatedParties
39000 usd
CY2022Q1 us-gaap Variable Lease Cost
VariableLeaseCost
13694000 usd
CY2023Q1 sem Variable Lease Cost Unrelated Parties
VariableLeaseCostUnrelatedParties
15761000 usd
CY2023Q1 sem Variable Lease Cost Related Parties
VariableLeaseCostRelatedParties
84000 usd
CY2023Q1 us-gaap Variable Lease Cost
VariableLeaseCost
15845000 usd
CY2022Q1 sem Sublease Income Unrelated Parties
SubleaseIncomeUnrelatedParties
1966000 usd
CY2022Q1 sem Sublease Income Related Parties
SubleaseIncomeRelatedParties
0 usd
CY2022Q1 us-gaap Sublease Income
SubleaseIncome
1966000 usd
CY2023Q1 sem Sublease Income Unrelated Parties
SubleaseIncomeUnrelatedParties
1678000 usd
CY2023Q1 sem Sublease Income Related Parties
SubleaseIncomeRelatedParties
0 usd
CY2023Q1 us-gaap Sublease Income
SubleaseIncome
1678000 usd
CY2022Q1 sem Lease Cost Unrelated Parties
LeaseCostUnrelatedParties
86373000 usd
CY2022Q1 sem Lease Cost Related Parties
LeaseCostRelatedParties
1848000 usd
CY2022Q1 us-gaap Lease Cost
LeaseCost
88221000 usd
CY2023Q1 sem Lease Cost Unrelated Parties
LeaseCostUnrelatedParties
91429000 usd
CY2023Q1 sem Lease Cost Related Parties
LeaseCostRelatedParties
1918000 usd
CY2023Q1 us-gaap Lease Cost
LeaseCost
93347000 usd
CY2023Q1 sem Long Term Debt Gross And Finance Lease Obligation
LongTermDebtGrossAndFinanceLeaseObligation
3879101000 usd
CY2023Q1 us-gaap Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
-16184000 usd
CY2023Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
14553000 usd
CY2023Q1 sem Long Term Debt And Finance Lease Obligation
LongTermDebtAndFinanceLeaseObligation
3880732000 usd
CY2023Q1 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
3832621000 usd
CY2023Q1 sem Long Term Debt And Finance Lease Obligation Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtAndFinanceLeaseObligationRepaymentsOfPrincipalRemainderOfFiscalYear
24685000 usd
CY2023Q1 sem Long Term Debt And Finance Lease Obligation Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
152429000 usd
CY2023Q1 sem Long Term Debt And Finance Lease Obligation Maturities Repayments Of Principal In Year Two
LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInYearTwo
2464015000 usd
CY2023Q1 sem Long Term Debt And Finance Lease Obligation Maturities Repayments Of Principal In Year Three
LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInYearThree
1226308000 usd
CY2023Q1 sem Long Term Debt And Finance Lease Obligation Maturities Repayments Of Principal In Year Four
LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInYearFour
823000 usd
CY2023Q1 sem Long Term Debt And Finance Lease Obligation Maturities Repayments Of Principal After Year Four
LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalAfterYearFour
10841000 usd
CY2023Q1 sem Long Term Debt Gross And Finance Lease Obligation
LongTermDebtGrossAndFinanceLeaseObligation
3879101000 usd
CY2022Q4 sem Long Term Debt Gross And Finance Lease Obligation
LongTermDebtGrossAndFinanceLeaseObligation
3878237000 usd
CY2022Q4 us-gaap Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
-17179000 usd
CY2022Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
15854000 usd
CY2022Q4 sem Long Term Debt And Finance Lease Obligation
LongTermDebtAndFinanceLeaseObligation
3879562000 usd
CY2022Q4 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
3767795000 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1599547000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1664980000 usd
CY2022Q1 sem Adjusted Ebitda
AdjustedEbitda
163847000 usd
CY2023Q1 sem Adjusted Ebitda
AdjustedEbitda
214063000 usd
CY2022Q1 us-gaap Assets
Assets
7535944000 usd
CY2023Q1 us-gaap Assets
Assets
7699736000 usd
CY2022Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
46845000 usd
CY2023Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
58885000 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
103985000 usd
CY2022Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
5397000 usd
CY2022Q1 us-gaap Interest Expense
InterestExpense
35514000 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
73868000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
151457000 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
8556000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
48571000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
111442000 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1599547000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1664980000 usd
CY2022Q1 us-gaap Dividends And Interest Paid
DividendsAndInterestPaid
0 usd
CY2023Q1 us-gaap Dividends And Interest Paid
DividendsAndInterestPaid
0 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
55926000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
85257000 usd
CY2022Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
6809000 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
14452000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
49117000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
70805000 usd
CY2022Q1 us-gaap Participating Securities Distributed And Undistributed Earnings Loss Diluted
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted
1643000 usd
CY2022Q1 us-gaap Participating Securities Distributed And Undistributed Earnings Loss Basic
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic
1643000 usd
CY2023Q1 us-gaap Participating Securities Distributed And Undistributed Earnings Loss Diluted
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted
2573000 usd
CY2023Q1 us-gaap Participating Securities Distributed And Undistributed Earnings Loss Basic
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic
2573000 usd
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
47474000 usd
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
47474000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
68232000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
68232000 usd
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
47474000 usd
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
47474000 usd
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
129010000 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
129010000 shares
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.37
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.37
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
68232000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
68232000 usd
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
122553000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
122553000 shares
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.56
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.56
CY2022Q1 us-gaap Participating Securities Distributed And Undistributed Earnings Loss Diluted
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted
1643000 usd
CY2022Q1 us-gaap Participating Securities Distributed And Undistributed Earnings Loss Basic
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic
1643000 usd
CY2022Q1 us-gaap Incremental Common Shares Attributable To Participating Nonvested Shares With Non Forfeitable Dividend Rights
IncrementalCommonSharesAttributableToParticipatingNonvestedSharesWithNonForfeitableDividendRights
4464000 shares
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.37
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.37
CY2023Q1 us-gaap Participating Securities Distributed And Undistributed Earnings Loss Diluted
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted
2573000 usd
CY2023Q1 us-gaap Participating Securities Distributed And Undistributed Earnings Loss Basic
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic
2573000 usd
CY2023Q1 us-gaap Incremental Common Shares Attributable To Participating Nonvested Shares With Non Forfeitable Dividend Rights
IncrementalCommonSharesAttributableToParticipatingNonvestedSharesWithNonForfeitableDividendRights
4622000 shares
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.56
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.56
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
49117000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
70805000 usd

Files In Submission

Name View Source Status
sem-20230331_def.xml Edgar Link unprocessable
sem-20230331_pre.xml Edgar Link unprocessable
sem-20230331_cal.xml Edgar Link unprocessable
sem-20230331_lab.xml Edgar Link unprocessable
0001628280-23-015781-index-headers.html Edgar Link pending
0001628280-23-015781-index.html Edgar Link pending
0001628280-23-015781.txt Edgar Link pending
0001628280-23-015781-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
sem-20230331.htm Edgar Link pending
sem-20230331.xsd Edgar Link pending
sem-331202310qxex311.htm Edgar Link pending
sem-331202310qxex312.htm Edgar Link pending
sem-331202310qxex321.htm Edgar Link pending
Show.js Edgar Link pending
sem-20230331_htm.xml Edgar Link completed